NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-081-1987-0-RO-08 Compositions Anti-HTLV III RO National Stage C-20143 Expired
NCI E-462-1985-0-HK-07 ANTIVIRAL COMPOSITIONS AND METHODS HK National Stage 0679-02-23 Expired
NCI E-462-1985-0-IE-10 ANTIVIRAL COMPOSITIONS AND METHODS IE EP 2264/86 Expired
NCI E-081-1987-0-HK-15 INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-... HK National Stage 94000270 Expired
NCI E-462-1985-0-IT-11 ANTIVIRAL COMPOSITIONS AND METHODS IT EP 86306495.2 Expired
NCI E-462-1985-0-SE-19 ANTIVIRAL COMPOSITIONS AND METHODS SE EP 86306495.2 Expired
NCI E-462-1985-0-CH-15 ANTIVIRAL COMPOSITIONS AND METHODS CH EP 86306495.2 Expired
NCI E-462-1985-0-GB-16 ANTIVIRAL COMPOSITIONS AND METHODS GB EP 86306495.2 Expired
NCI E-462-1985-0-BE-05 ANTIVIRAL COMPOSITIONS AND METHODS BE EP 86306495.2 Expired
NCI E-462-1985-0-AT-03 ANTIVIRAL COMPOSITIONS AND METHODS AT EP 86306495.2 Expired
NCI E-462-1985-0-NL-13 Inhibition of In Vitro Infectivity and Cytopathic Effect of HTLV-III/LAV By... NL EP 86306495.2 Expired
NCI E-462-1985-0-LU-17 ANTIVIRAL COMPOSITIONS AND METHODS LU EP 86306495.2 Expired
NCI E-462-1985-0-DE-08 ANTIVIRAL COMPOSITIONS AND METHODS DE EP 86306495.2 Expired
NCI E-462-1985-0-FR-09 ANTIVIRAL COMPOSITIONS AND METHODS FR EP 86306495.2 Expired
NCI E-081-1987-0-FR-03 INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3' - DIDEOXYADENOSINE FR EP 86306494.5 Expired
NCI E-081-1987-0-AT-21 INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-... AT EP 86306494.5 Expired
NCI E-081-1987-0-BE-23 INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-... BE EP 094C0006 Expired
NCI E-462-1985-0-SG-20 ANTIVIRAL COMPOSITIONS AND METHODS SG National Stage 9590585.7 Expired
NCI E-462-1985-0-IL-14 ANTIVIRAL COMPOSITIONS AND METHODS IL National Stage 79699 Expired
NCI E-435-1985-0-CA-05 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS CA National Stage 515585 Expired
NCI E-462-1985-0-CA-06 ANTIVIRAL COMPOSITIONS AND METHODS CA National Stage 515943 Expired
NCI E-462-1985-0-JP-12 ANTIVIRAL COMPOSITIONS AND METHODS JP National Stage 1986-504539 Expired
NCI E-081-1987-0-JP-12 INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-... JP National Stage 1986-504427 Expired
NCI E-462-1985-0-AU-04 ANTIVIRAL COMPOSITIONS AND METHODS AU National Stage 62843/86 Expired
NCI E-081-1987-0-AU-22 INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-... AU National Stage 61968/86 Expired
NCI E-081-1987-0-PCT-02 INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3' - DIDEOXYGUANOSINE, OR 2'3'-DIDEOXYADENOSINE PCT PCT PCT/US1986/001622 Expired
NCI E-462-1985-0-PCT-02 INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYCYTIDINE PCT PCT PCT/US1986/001626 Expired
NCI E-435-1985-0-JP-10 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS JP National Stage 1986-186711 Abandoned
NCI E-435-1985-0-LU-11 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS LU EP 86401770.2 Expired
NCI E-435-1985-0-IT-09 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS IT EP 86401770.2 Expired
NCI E-435-1985-0-NL-08 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS NL EP 86401770.2 Expired
NCI E-435-1985-0-GB-13 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS GB EP 86401770.2 Expired
NCI E-435-1985-0-CH-12 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS CH EP 86401770.2 Expired
NCI E-435-1985-0-SE-14 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS SE EP 86401770.2 Expired
NCI E-435-1985-0-AT-03 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS AT EP 86401770.2 Expired
NCI E-435-1985-0-BE-04 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS BE EP 86401770.2 Expired
NCI E-435-1985-0-FR-07 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS FR EP 86401770.2 Expired
NCI E-435-1985-0-DE-06 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS DE EP 86401770.2 Expired
NCI E-435-1985-0-EP-15 ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS EP National Stage 86401770.2 Expired
NIDCR E-182-1984-0-US-01 SYSTEMATIC METHOD FOR MATCHING EXISTING RADIOGRAPHIC PROJECTIONS WITH RADIOGRAPHS TO BE PRODUCED FROM A SPECIFIE US ORD 06/894,251 4769756 Expired PDF
NCI E-454-1986-0-US-01 Human B Lymphotropic (HBLV) Isolation and Process US ORD 06/892,423 Abandoned
NCI E-100-1986-1-US-01 COMPOSITIONS AND METHODS FOR CLONES CONTAINING DNA SEQUENCES ASSOCIATED WITH MULTIDRUG RESISTANCE IN HUMAN... US CIP 06/892,575 Abandoned
NCI E-183-1987-0-US-01 Recombinant HTLV-III Proteins and Uses Thereof US ORD 06/892,680 Abandoned
NCI E-258-1986-0-US-01 Deletion Mutants and Monoclonal Antibodies Against RAS Proteins US ORD 06/890,510 4820631 Expired PDF
NICHD E-174-1986-0-US-01 FERMENTATION LEVEL CULTIVATION OF BORDETELLA PERTUSSIS US ORD 06/889,621 Abandoned
NIDDK E-130-1986-0-US-01 SCREENING FOR TAY-SACHS DISEASE WITH CLONED DNA FOR BETA-HEXOSAMINIDASE US ORD 06/889,502 Abandoned
NCI E-160-1986-0-US-01 MONOCLONAL ANTIBODY AGAINST OVARIAN CANCER CELLS (0VB-3) US ORD 06/888,960 4806494 Expired PDF
NIAID E-164-1986-0-US-01 IGE FC DIRECTED DELIVERY SYSTEM US ORD 06/888,059 4902495 Abandoned PDF
NCI E-259-1986-0-US-01 USE OF MONOCYTE/MACROPHAGES IN THE PRODUCTION OF HTLV-III/LAV VIRUS [BA-L #510] US ORD 06/884,512 Abandoned
NCI E-317-1984-1-US-30 SEROLOGICAL DETECTION OF ANTIBODIES TO HTLV-III IN SER PATIENTS WITH AIDS AND PRE-AIDS CONDITIONS US CON 06/883,027 Abandoned